Combined percutaneous transhepatic biliary drainage with port implantation for management of patients with malignant biliary obstruction - 24/08/11
Reprint requests: Karel Caca, MD, Department of Medicine II, University of Leipzig, Philipp-Rosenthal Str. 27, 04103, Leipzig, Germany.Abstract |
Background |
Endoscopic biliary stent insertion has become a standard palliative treatment for patients with obstructive jaundice caused by malignancies of the hepatobiliary system or metastases of other tumors, such as pancreatic or gastric cancer. Unfortunately, bacterial colonization and encrustation frequently leads to occlusion of plastic stents and, consequently, recurrent cholangitis.
Methods |
An external-internal Yamakawa-type endoprosthesis was modified and combined with a titanium, subcutaneously implanted port. This technique was evaluated as a new approach to prolongation of stent patency and prevention of cholangitis. Two patients with obstructive jaundice, one with recurrent gastric carcinoma and the other with invasive gallbladder cancer, underwent treatment with this new method.
Results |
Effective biliary drainage was established and cholangitis was prevented in both patients for 6 and 2 months, respectively.
Conclusions |
A new method of percutaneous transhepatic drainage combined with port implantation was effective and safe in two patients. This technique may be a reasonable treatment option for selected patients, but further evaluation in a larger series is required to establish efficacy and safety.
Le texte complet de cet article est disponible en PDF.Plan
Vol 60 - N° 1
P. 117-120 - juillet 2004 Retour au numéro
Article précédent
- Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity
- Anthony N Kalloo, Vikesh K Singh, Sanjay B Jagannath, Hideaki Niiyama, Susan L Hill, Cheryl A Vaughn, Carolyn A Magee, Sergey V Kantsevoy
- Photodynamic therapy of superficial esophageal cancer with a transparent hood
- Tetsuya Nakamura, Hirokazu Fukui, Katsuro Shirakawa, Youichirou Fujii, Takahiro Fujimori, Akira Terano
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?